Pharmacotherapy

Top Research Topics at Pharmacotherapy?

The journal focuses largely on the fields of Internal medicine, Anesthesia, Surgery, Intensive care medicine and Pharmacology. In Pharmacotherapy, Gastroenterology, Endocrinology and Cardiology are investigated in conjunction with one another to address concerns in Internal medicine research. The Cardiology study tackling the subject of Heart failure is the focus of Pharmacotherapy.

Most of the works presented in the journal deals with Anesthesia but it intersects with the subject of Placebo. Surgery research featured in it incorporates concerns from various other topics such as Antibacterial agent and Warfarin. Antibiotics, Pharmacotherapy, Disease and Clinical trial are some topics wherein Intensive care medicine research discussed in it have an impact.

Pharmacokinetics, Drug interaction and Drug are all areas of Pharmacology tackled in the journal. Pharmacotherapy holds forums on Pharmacokinetics that merges themes from other disciplines such as Oral administration, Crossover study and Dosing.

• Internal medicine (32.78%)
• Anesthesia (21.63%)
• Surgery (18.13%)

What are the most cited papers published in the journal?

• Attention-deficit-hyperactivity disorder: an update. (599 citations)
• Update: Clinically Significant Cytochrome P‐450 Drug Interactions (524 citations)
• Validity of the general practice research database. (521 citations)

Research areas of the most cited articles at Pharmacotherapy:

The published papers investigate areas of study like Internal medicine, Pharmacology, Anesthesia, Surgery and Intensive care medicine. The published articles with studies in Internal medicine featured incorporate elements of Gastroenterology and Endocrinology. The journal publications tackle studies in Randomized controlled trial and the interrelated subject of Physical therapy to gain insights into Anesthesia.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Surgery

The previous edition focused in particular on these issues:

Pharmacotherapy primarily tackles Internal medicine, Intensive care medicine, Dosing, Retrospective cohort study and Anesthesia. Pharmacotherapy facilitates discussions on Internal medicine that incorporate concepts from other fields like Gastroenterology and Cardiology. Pharmacotherapy explores research in Solid organ transplantation and overlapping concepts in Patient survival to expand the discourse in Intensive care medicine.

Pharmacotherapy focuses on Dosing but the discussions also offer insight into other areas such as Pharmacokinetics and Systematic review. In addition to Retrospective cohort study research, the journal aims to explore topics under Odds ratio, Incidence (epidemiology), Confidence interval, Clinical endpoint and Vancomycin. Pharmacotherapy explores topics in Anesthesia which can be helpful for research in disciplines like Intensive care unit and Bleed.

The most cited articles from the last journal are:

• Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective. (5 citations)
• Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired renal function and those requiring hemodialysis (3 citations)
• A guide to therapeutic drug monitoring of β-lactam antibiotics (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Pharmacotherapy (based on the number of publications) are:

• Michael J. Rybak (50 papers) absent at the last edition,
• Sarah A. Spinler (40 papers) absent at the last edition,
• Hershel Jick (37 papers) absent at the last edition,
• Barry L. Carter (35 papers) absent at the last edition,
• Daniel E. Hilleman (35 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Pharmacotherapy (based on the number of publications) are:

• University of Illinois at Chicago (214 papers) published 9 papers at the last edition, 2 more than at the previous edition,
• University of North Carolina at Chapel Hill (150 papers) published 5 papers at the last edition,
• University of Michigan (147 papers) published 5 papers at the last edition, 3 less than at the previous edition,
• Veterans Health Administration (146 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• University of Minnesota (141 papers) published 1 paper at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.12% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 30.11% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.53% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.05% of all publications and 47.31% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Pathways to Becoming a Nurse Practitioner in Massachusetts

The article is packed with valuable data about research and statistics on Pharmacotherapy. However, it lacks practical information for our readers who might be interested in exploring related fields in the healthcare sector. A useful section that could be added would expound on how one can pursue a career in the healthcare field. For instance, becoming a nurse practitioner in Massachusetts is a career path closely linked to Pharmacotherapy. This section provides insights on how one can venture into this field. A Nurse Practitioner (NP) is an advanced practice registered nurse (APRN) who has additional responsibilities for administering patient care than RNs. Nurse Practitioners can prescribe medication, examine patients, diagnose illnesses, and provide treatment, much like physicians do. To pursue this career, a candidate must first earn a Registered Nursing license, followed by a Master's degree or Doctorate in a specialized nursing program. Additionally, candidates must obtain a national certification as an NP from a recognized body. The path to becoming a nurse practitioner demands rigorous education, a commitment to patient care, but it offers the reward of strong job prospects and competitive salaries. Pharmacotherapy is an integral component of the NP role, as they need to understand drug interactions, appropriate dosing, and the latest medical research. If you wish to know more in-depth details about career progression, certifications, and educational programs available in Massachusetts, visit our detailed guide on how to become a nurse practitioner in Massachusetts.